International regulatory review: Israel

This paper is one of a series of country case studies reviewing nations’ regulatory body for the healthcare industry. It reports Israel’s modern regulatory environment and the social background that has shaped its unique agency structure and functionalities. With the Ministry of Health acting as a combination regulatory body, international trade negotiator, and industry supporter, Israel has established a complex partnership relation between government and industry without compromising the regulatory functions of the agency. The result is a focus on protecting Israeli citizen’s health and safety; expanding exports; and assuring the quality of pharmaceutical imports.